Abstract:Human milk alone has insufficient nutrients to meet preterm infant requirements and a multi-nutrient fortifier, bovine milk-based (BMBF) or human milk-based (HMBF), is recommended. As the nutrient composition of BMBF and HMBF differs [1, 2], the biochemical effects may also differ; these differences have not yet been reported. This secondary analysis of a randomized controlled trial comparing BMBF and HMBF examined the biochemical response to the different fortifiers in preterm infants which were hypothesized to differ given different intakes of protein and iron [3]. Infants born <1250 g who met eligibility criteria for the Optimizing Mothers' Milk for Preterm Infants (OptiMoM) trial (NCT02137473) were studied [3]. Following informed consent, infants were provided mother's milk first then pasteurized donor milk as required and had BMBF or HMBF added to human milk feeds in a blinded fashion depending on their randomization. The HMBF group received Prolact+4 and +6 (Prolacta Bioscience, City of Industry, USA) commencing at 100 mL/kg/day (81 kcal/dL, 2.2 g/dL protein, 0.1 mg/dL iron) and 140 mL/kg/day (88 kcal/dL, 2.7 g/dL protein, 0.2 mg/dL iron), respectively. In the BMBF group, 0.4 g/dL intact protein modular (Beneprotein, Nestle, Minneapolis, USA) was added to donor milk and Similac Human Milk Fortifier (Abbott Nutrition, Columbus, USA) 1:50 and 1:25 commenced at 100 mL/kg/day (72 kcal/dL, 1.7 g/dL protein, 0.2 mg/dL iron) and 140 mL/kg/day (78 kcal/dL, 2.2 g/dL protein, 0.4 mg/dL iron), respectively. Parenteral nutrition was discontinued at 120 mL/kg/day, enteral volumes increased 10-25 mL/kg/day, full feeds were considered 160 mL/kg/day, and energy increases were implemented if weight gain was <15 g/kg/day using Prolact+8 (95 kcal/dL) or Neosure (88 kcal/dL, Abbott Nutrition, Columbus, USA) in HMBF and BMBF groups, respectively. Both groups received multivitamin drops containing 375IU vitamin A, 200IU vitamin D and 17.5 mg vitamin C daily. Vitamin D 200IU was given daily until 2 kg. Each infant received 2-3 mg/kg/day elemental iron after full fortification. These doses were chosen bearing in mind the different micronutrient composition of the two diets while providing the same supplementation to both groups and thus maintaining blinding. The intervention lasted until 84 days of age, hospital discharge or establishment of oral feeds. The initial trial found no group differences in feeding tolerance or growth [3].

Effect of protein fortification on heat damage and occurrence of β-casomorphins in (un)digested donor human milk intended for nutrition of preterm infants

Peptidomic profile of human milk as influenced by fortification with different protein sources: An in vitro dynamic digestion simulation

The Effect of Donor Human Milk Fortification on The Adhesion of Probiotics In Vitro

Differential impact of Holder and High Temperature Short Time pasteurization on the dynamic in vitro digestion of human milk in a preterm newborn model

Human Milk Fortification with Bovine Colostrum Is Superior to Formula‐Based Fortifiers to Prevent Gut Dysfunction, Necrotizing Enterocolitis, and Systemic Infection in Preterm Pigs

Biochemical response in preterm infants fed a human versus bovine milk-based fortifier

Comparative proteomic analysis of donor human milk treated by high-pressure processing or Holder pasteurization on undigested proteins across dynamic simulated preterm infant digestion

Preterm Birth and Human Milk Proteome: Are We Ready for Individualized Fortification?

Donor human milk processing and its impact on infant digestion: A systematic scoping review of in vitro and in vivo studies

Effects of human donor milk on gut barrier function and inflammation: in vitro study of the beneficial properties to the newborn

Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants

Beyond the gut: Investigating the mechanism of formation of β-casomorphins in human blood

Structural and functional changes of bioactive proteins in donor human milk treated by vat-pasteurization, retort sterilization, ultra-high-temperature sterilization, freeze-thawing and homogenization

Systemic immune markers and infection risk in preterm infants fed human milk fortified with bovine colostrum or conventional fortifier, a secondary analysis of the FortiColos trial

Association of Fortification with Human Milk Versus Bovine Milk-Based Fortifiers on Short-Term Outcomes in Preterm Infants—A Meta-Analysis

In Vivo Assessment of Antioxidant Potential of Human Milk Treated by Holder Pasteurization or High Hydrostatic Pressure Processing: A Preliminary Study on Intestinal and Hepatic Markers in Adult Mice

Human milk-based fortifier is associated with less alteration of milk fat globule size than cow milk-based fortifier

Effect of In Vitro Digestion on Bioactive Peptides Related to Immune and Gut Health in Intact Cow's Milk and Hydrolyzed Protein-Based Infant Formulas

Investigating Milk Fat Globule Structure, Size, and Functionality after Thermal Processing and Homogenization of Human Milk

Source of human milk (mother or donor) is more important than fortifier type (human or bovine) in shaping the preterm infant microbiome

The Sterilization of Human Milk by Holder Pasteurization or by High Hydrostatic Pressure Processing Leads to Differential Intestinal Effects in Mice